Spotlight

UCL cancer immunotherapy company, Autolus, launches with £30m investment

A new UCL spin-out company – Autolus – is being launched today to develop and commercialise a new generation of engineered T-cell therapies for haematological and solid tumours, with the backing of £30m in investment from healthcare investment company Syncona.

Find out more



follow us on twitter


How can you maximise the benefits when you present academic research to business audiences?

12 March 2014

Communicating Science to Business is a three-part mini-course that prepares academics and PhD students for presenting their research to business audiences with confidence and clarity.

A CPD Certificate is available to participants who have attended three workshops in the same academic year.

Who Can Attend?

UCL staff and PhD students

When:

Find out more and register for Communicating Science to Business